Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia, and major depression

Bipolar Disorders

Volumn 11, Issue 2, 2009, Pages 154-165

  Diaz, Francisco J ^a,d   James, Danielle ^b   Botts, Sheila ^b   Maw, Lorraine ^b   Susce, Margaret T ^b   De Leon, Jose ^b,c  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Eastern State Hospital   (United States)

^c UNIVERSITY OF GRANADA   (Spain)

^d EASTERN STATE HOSPITAL   (United States)

Author keywords

Bipolar disorder; Major depression; Nicotine; Schizophrenia; Smoking; Tobacco

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION;

EID: 61549091581     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00664.x     Document Type: Article

References (47)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
2. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135-157.
3. de Leon J, Gurpegui M, Diaz FJ. Epidemiology of comorbid tobacco use and schizophrenia: Thinking about risks and protective factors. J Dual Diagn 2007; 3: 9-25.
4. Campo-Arias A, Díaz-Martínez LA, Rueda-Jaimes GE et al. Smoking is associated with schizophrenia, but not with mood disorders, within a population with low smoking rates: A matched case-control study in Bucaramanga, Colombia. Schizophr Res 2006; 83: 269-276.
5. Salin-Pascual RJ, Rosas M, Jiménez-Genchi A, Rivera-Metz BL, Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996; 57: 387-389.
6. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998; 17: 35-46.
7. Hitsman B, Borrelli B, McChargue DE, Spring B, Niaura R. History of depression and smoking cessation outcome: A meta-analysis. J Consult Clin Psychol 2003; 71: 657-663.
8. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: A causal analysis. Arch Gen Psychiatry 1993; 50: 36-43.
9. Escobedo LG, Peddicord JP. Smoking prevalence in US birth cohorts: The influence of gender and education. Am J Public Health 1996; 86: 231-236.
10. de Leon J, Susce MT, Diaz FJ, Rendon DM, Velásquez DM. Variables associated with alcohol, drug and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry 2006; 66: 1447-1455.
11. de Leon J, Rendon DM, Baca-Garcia E et al. Association between smoking and alcohol use in the general population: Stable and unstable odds ratios across two years in two different countries. Alcohol 2007; 42: 252-257.
12. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA 2000; 284: 2606-2610.
13. Vanable PA, Carey MP, Carey KB, Maisto SA. Smoking among psychiatric outpatients: Relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav 2003; 17: 259-265.
14. Morris CD, Giese AA, Turnbull JJ, Dickinson M, Johnson-Nagel N. Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatr Serv 2006; 57: 1035-1038.
15. Waxmonsky JA, Thomas MR, Miklowitz DJ et al. Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry 2005; 27: 321-328.
16. Gonzalez-Pinto A, Gutierrez M, Ezcurra J et al. Tobacco smoking and bipolar disorder. J Clin Psychiatry 1998; 59: 225-228.
17. Dome P, Rihmer Z, Gonda X et al. Cigarette smoking and psychiatric disorders in Hungary. Int J Psychiatry Clin Practice 2005; 9: 145-148.
18. Gurpegui M, Martinez-Ortega JM, Aguilar MC, Diaz FJ, Quintana HM, de Leon J. Smoking initiation and schizophrenia: A replication study in a Spanish sample. Schizophr Res 2005; 76: 113-118.
19. de Leon J, Susce MT, Pan RM, Fairchild M, Koch WH, Wedlund PJ. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. J Clin Psychiatry 2005; 66: 15-27.
20. Diaz FJ, JanéM, SaltóE et al. A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust NZ J Psychiatry 2005; 39: 161-168.
21. Leach RC. Kentucky Behavioral Risk Factor Surveillance System. 2001 Report. Frankfort, KY: Kentucky Department for Public Health, Division of Epidemiology and Health Planning, 2003.
22. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 2002; 56: 47-54.
23. Simon JL. Resampling Stats User's Guide. Arlington, VA: Resampling Stats, Inc., 1999.
24. Woodward M. Epidemiology. Study Design and Data Analysis. 2nd edn. Boca Raton, FL: Chapman & Hall/CRC, 2005.
25. Borenstein M, Rothstein H, Cohen J. Power and Precision. A Computer Program for Statistical Power Analysis and Confidence Intervals. Englewood, NJ: Biostat® Software Products, 2001.
26. Itkin O, Nemets B, Einat H. Smoking habits in bipolar and schizophrenic outpatients in southern Israel. J Clin Psychiatry 2001; 62: 269-272.
27. Ucok A, Polat A, Bozkurt O, Meteris H. Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry Clin Neurosci 2004; 58: 434-437.
28. Covey LS, Hughes DC, Glassman AH et al. Ever-smoking, quitting, and psychiatric disorders: Evidence from the Durham, North Carolina, and Epidemiological Catchment Area. Tob Control 1994; 3: 222-227.
29. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990; 264: 2511-2518.
30. Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults and the proportion of adults who work in a smoke-free environment -United States, 1999. MMWR 2000; 49: 978-982.
31. Centers for Disease Control and Prevention (CDC). State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18-35years -United States, 2006. MMWR 2007; 56: 993-996.
32. Weinberger AH, George TP, Perkins KA, Chengappa KN. Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type. J Clin Psychopharmacol 2008; 28: 247-248.
33. Labbate LA. Nicotine cessation, mania, and depression. Am J Psychiatry 1992; 149: 708.
34. Benazzi F. Severe mania following abrupt nicotine withdrawal. Am J Psychiatry 1989; 146: 1641.
35. Kohen I, Kremen N. Varenicline-induced manic episode in a patient with bipolar disorder. Am J Psychiatry 2007; 164: 1269-1270.
36. Michael N, Erfurth A, Bergant V. A case report of mania related to discontinuation of bupropion therapy for smoking cessation. J Clin Psychiatry 2004; 65: 277.
37. West R. Bupropion SR for smoking cessation. Expert Opin Pharmacother 2003; 4: 533-540.
38. Gonzales D, Rennard SI, Nides M et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor parcial agonist, vs. sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA 2006; 296: 47-55.
39. Popkin M. Exacerbation of recurrent depression as results of treatment with varenicline (letter). Am J Psychiatry 2008; 165: 774.
40. Gelenberg AJ, de Leon J, Evins AE, Parks JJ, Rigotti NA. Smoking cessation in patients with psychiatric disorders. J Clin Psychiatry 2007; 68: 1404-1410.
41. de Leon J. Smoking and vulnerability for schizophrenia. Schizophr Bull 1996; 22: 405-409.
42. Freedman R, Coon H, Myles-Worsley M et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94: 587-592.
43. de Leon J, Becoña E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry 2002; 63: 812-816.
44. Aguilar MC, Gurpegui M, Diaz FJ, de Leon J. Nicotine dependence and symptoms in schizophrenia: Naturalistic study of complex interactions. Br J Psychiatry 2005; 186: 215-221.
45. Kolb GF, Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science 1997; 278: 52-58.
46. de Leon J, Diaz FJ, Aguilar MC, Jurado D, Gurpegui M. Does smoking reduce akathisia?: Testing a narrow version of the self-medication hypothesis. Schizophr Res 2006; 86: 256-268.
47. Hughes JR, Howard TS. Nicotine and caffeine use as confounds in psychiatric studies. Biol Psychiatry 1997; 42: 1184-1185.